CGEM
Cullinan Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Cullinan Therapeutics (CGEM) Stock: Buy, Sell, or Hold?
$11.35
+0.12 (+1.07%)
▲
5d:
-9.13%
30d:
-19.5%
90d:
-42.21%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$13.74 – $15.75
Position: OVERSOLD
Forward P/E & Valuation
-4.6x
Next 12M consensus est.
Wall Street Target
$34.60
+204.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.69 / $16.29
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CGEM shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CGEM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CGEM is currently trading at $11.35, which is considered oversold relative to its 30-day fair value range of $13.74 to $15.75.
Technical Outlook: Technically, CGEM is in a downtrend. Immediate support is located at $10.69, while resistance sits at $16.29.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.60 (+204.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CGEM is in a downtrend. Immediate support is located at $10.69, while resistance sits at $16.29.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.60 (+204.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.74 -
$15.75
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$13.74 -
$15.75
Current vs Trading Range
OVERSOLD
Support Level
$10.69
Resistance Level
$16.29
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 204.8% below Wall St target ($34.60)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-4.59
Wall Street Target
$34.60
(+204.8%)
Share CGEM Analysis
Share this live CGEM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CGEM)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses confidence in $CGEM reaching $20 by year-end, citing significant de-risking.
Key Retail Themes:
Bullish outlook
De-risking
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
PALI
Palisade Bio Inc |
STRONG BUY
10 analysts |
$10 | 62 BUY |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$42 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CGEM Research Pages
